Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02561429
Other study ID # si645/2012
Secondary ID
Status Completed
Phase N/A
First received September 15, 2015
Last updated May 2, 2016
Start date July 2013
Est. completion date August 2015

Study information

Verified date May 2016
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority Thailand: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Skin prick test (SPT) was used for diagnostic test for type 1 hypersensitivity. The efficacy and safety of SPT were proved. The positive control of SPT is histamine.

In Thailand, the most common concentration of histamine for SPT is 10 mg/ml. However, in some practice they use other concentration (1, 2.5 mg/ml).

This study will find the proper concentration of histamine for positive control use in SPT.


Description:

Appropriate concentration of histamine positive control is important in interpretation the result of skin prick test.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date August 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 7 Years to 60 Years
Eligibility Inclusion Criteria:

- Parcitipate person who attented allergy clinic, ENT clinic

- Legible in Thai language

Exclusion Criteria:

- Patient cannot withhold antihistamine drug

- Pragnancy and lactation mother

- comorbid disease such as cardiac disease, liver, renal, hypertension and severe asthma

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Procedure:
SPT
SPT of histamine concentration 1, 5 and 10 mg/ml

Locations

Country Name City State
Thailand Faculty of Medicine Siriraj Hospital Bangkoknoi Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

References & Publications (2)

Berkowitz RB, Tinkelman DG, Lutz C, Crummie A, Smith K. Evaluation of the Multi-Test device for immediate hypersensitivity skin testing. J Allergy Clin Immunol. 1992 Dec;90(6 Pt 1):979-85. — View Citation

Ménardo JL, Bousquet J, Rodière M, Astruc J, Michel FB. Skin test reactivity in infancy. J Allergy Clin Immunol. 1985 Jun;75(6):646-51. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mean wheal diameters of SPT of different histamine concentrations. compare mean wheal diameters of histamine concentration 1,5, and 10 mg/ml 1 years Yes
Secondary Mean wheal diameters of SPT of local and imported histamine positive concentration compare mean wheal diameters of imported histamine 1 mg/ml to local histamine 1 year Yes
See also
  Status Clinical Trial Phase
Recruiting NCT06065137 - Standardised Drug Provocation Testing in Perioperative Hypersensitivity N/A
Completed NCT00850668 - Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults Phase 1
Completed NCT02561390 - Comparison Between spIgE and Skin Prick Test of Local and Imported Aeroallergens N/A
Completed NCT00461097 - Oral Immunotherapy for Childhood Egg Allergy Phase 2
Completed NCT01084174 - A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy Phase 1/Phase 2
Completed NCT01407640 - Diagnosis and Physiopathology of Insulin Allergy N/A
Completed NCT00580606 - A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial Phase 1/Phase 2